Diabetologia (2015) 58: 429–442 DOI 10.1007/s00125-014-3460-0 management of
hyperglycaemia in patients with type 2 diabetes [1, 2]. This was needed because of an …

In 2012, the American Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD) published a position statement on the management of …

Moderate aLimited use in the US/Europe. bNot licensed in the US cPrescribing highly
restricted in the US; withdrawn in Europe. dNot licensed in Europe. eTo be available as a …

The American Diabetes Association and the European Association for the Study of Diabetes
have briefly updated their 2018 recommendations on management of hyperglycemia, based …

The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the prior position statements, published in 2012 and 2015, on …

Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the prior position statements, published in 2012 and …

The epidemic of type 2 diabetes in the latter part of the 20th and in the early 21st century,
and the recognition that achieving specific glycaemic goals can substantially reduce …

The epidemic of type 2 diabetes in the latter part of the 20th and in the early 21st century,
and the recognition that achieving specific glycemic goals can substantially reduce …

Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …

Despite increasingly stringent clinical practice guidelines for glycaemic control, the
implementation of recommendations has been disappointing, with over 60% of patients not …